Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Giant Biogene Holding Co. Ltd. (HK:2367)

HKEX:2367

2367

Giant Biogene Holding Co. Ltd.

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding HK:2367?

Track your performance easily

Link Broker

Giant Biogene Holding Co. Ltd. (2367) Stock Price & Analysis

0 Followers

2367 Stock Chart & Stats

Advanced Chart >

Day’s RangeHK$0 - HK$0

52-Week RangeHK$28.75 - HK$54.40

Previous CloseHK$37.25

Volume4.56M

Average Volume (3M)2.90M

Market Cap

HK$37.59B

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)19.1

Beta0.71

Next Earnings

Mar 31, 2025

EPS Estimate

HK$1.09

Last Dividend Ex-Date

Jun 17, 2024

Dividend Yield1.34%

Share Statistics

EPS (TTM)1.95

Shares OutstandingN/A

10 Day Avg. Volume2,834,501

30 Day Avg. Volume2,899,851

Standard Deviation0.13

R-Squared0.23

Alpha0.03

Financial Highlights & Ratios

Price to Book (P/B)0.00

Price to Sales (P/S)N/A

Price to Cash Flow (P/CF)N/A

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

HK$58.54

Price Target Upside57.15% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering3

Giant Biogene Holding Co. Ltd. News

PremiumCompany Announcements

Giant Biogene’s Remarkable Mid-Year Financial Surge

1M ago

2367

PremiumCompany Announcements

Giant Biogene Schedules Key Financial Meeting

2M ago

2367

PremiumCompany Announcements

Giant Biogene Shareholders Approve Dividends and Resolutions

3M ago

2367

PremiumCompany Announcements

Giant Biogene Declares Year-End Cash Dividend

3M ago

2367

PremiumCompany Announcements

Giant Biogene Declares Special Dividend

3M ago

2367

PremiumCompany Announcements

Giant Biogene Advances to Digital Shareholder Communications

3M ago

2367

PremiumCompany Announcements

Giant Biogene Adopts Electronic Communication

3M ago

2367

PremiumCompany Announcements

Giant Biogene Secures Funds for Expansion

4M ago

2367

See More HK:2367 News >

Options Prices

Currently, No data available

---

Ownership Overview

0.00%

Insiders

1.68% Mutual Funds

2.41% Other Institutional Investors

95.91% Public Companies and

Individual Investors

Detailed Ownership Overview >

2367 FAQ

What was Giant Biogene Holding Co. Ltd.’s price range in the past 12 months?

Giant Biogene Holding Co. Ltd. lowest stock price was HK$28.75 and its highest was HK$54.40 in the past 12 months.

What is Giant Biogene Holding Co. Ltd.’s market cap?

Currently, no data Available

When is Giant Biogene Holding Co. Ltd.’s upcoming earnings report date?

Giant Biogene Holding Co. Ltd.’s upcoming earnings report date is Mar 31, 2025 which is in 192 days.

How were Giant Biogene Holding Co. Ltd.’s earnings last quarter?

Giant Biogene Holding Co. Ltd. released its earnings results on Aug 19, 2024. The company reported HK$1.066 earnings per share for the quarter, beating the consensus estimate of HK$0.923 by HK$0.143.

Is Giant Biogene Holding Co. Ltd. overvalued?

According to Wall Street analysts Giant Biogene Holding Co. Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Giant Biogene Holding Co. Ltd. pay dividends?

Giant Biogene Holding Co. Ltd. pays a Notavailable dividend of HK$0.48 which represents an annual dividend yield of 1.34%. See more information on Giant Biogene Holding Co. Ltd. dividends here

What is Giant Biogene Holding Co. Ltd.’s EPS estimate?

Giant Biogene Holding Co. Ltd.’s EPS estimate is HK$1.09.

How many shares outstanding does Giant Biogene Holding Co. Ltd. have?

Giant Biogene Holding Co. Ltd. has 1,028,220,000 shares outstanding.

What happened to Giant Biogene Holding Co. Ltd.’s price movement after its last earnings report?

Giant Biogene Holding Co. Ltd. reported an EPS of HK$1.066 in its last earnings report, beating expectations of HK$0.923. Following the earnings report the stock price went up 1.001%.

Which hedge fund is a major shareholder of Giant Biogene Holding Co. Ltd.?

Currently, no hedge funds are holding shares in HK:2367

---

Giant Biogene Holding Co. Ltd. Stock Smart Score

Unlock Smart Score

Analyst Consensus

Strong Buy

Average Price Target:
HK$58.54 (57.15% Upside)

Technicals

Fundamentals

Return on Equity

37.51%

Trailing 12-Months

Asset Growth

99.83%

Trailing 12-Months

Top Smart Score Stocks >

2367 Stock 12 Month Forecast

Average Price Target

HK$58.54

▲(57.15% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"29":"HK$29","46":"HK$46","63":"HK$63","37.5":"HK$37.5","54.5":"HK$54.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":62.07,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$62.07</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":58.54,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$58.54</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":55,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$55.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[29,37.5,46,54.5,63],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2023","6":"Dec<br/>2023","9":"Jun<br/>2024","12":"Sep<br/>2024","25":"Sep<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,39.6,41.32846153846154,43.05692307692308,44.785384615384615,46.51384615384615,48.24230769230769,49.970769230769235,51.699230769230766,53.42769230769231,55.15615384615384,56.88461538461539,58.61307692307692,60.34153846153846,{"y":62.07,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,39.6,41.05692307692308,42.51384615384615,43.970769230769235,45.42769230769231,46.88461538461539,48.34153846153846,49.79846153846154,51.255384615384614,52.71230769230769,54.169230769230765,55.62615384615384,57.08307692307692,{"y":58.54,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,39.6,40.784615384615385,41.96923076923077,43.15384615384615,44.33846153846154,45.52307692307692,46.707692307692305,47.892307692307696,49.07692307692308,50.261538461538464,51.44615384615385,52.63076923076923,53.815384615384616,{"y":55,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":34.1,"date":1688169600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":34.63,"date":1690848000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":36.84,"date":1693526400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":33.26,"date":1696118400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":32.97,"date":1698796800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":34.93,"date":1701388800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":34.93,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.66,"date":1704412800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.62,"date":1706832000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.85,"date":1719532800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.75,"date":1720137600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.55,"date":1722556800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.6,"date":1725580800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >

Technical Analysis

Similar Stocks

Koolearn Technology Holding Limited

―

6618

JD Health International, Inc.

―

6185

CanSino Biologics, Inc. Class H

―

Compare HK:2367 Stocks >

Best Analysts Covering 2367

1 Year

Lina YanHSBC

1 Year Success Rate

1/1 ratings generated profit

1 Year Average Return

+6.00%

initiated a buy rating 10 months ago

Copying Lina Yan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +6.00% per trade.

Best Analyst Covering >

Popular Stocks

---

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing